4.8 Article

Tissue-infiltrating neutrophils represent the main source of IL-23 in the colon of patients with IBD

期刊

GUT
卷 65, 期 10, 页码 1632-1641

出版社

BMJ PUBLISHING GROUP
DOI: 10.1136/gutjnl-2014-309014

关键词

-

资金

  1. Swedish Research Council
  2. Karolinska Institutet
  3. Stockholm County Council (ALF-project)
  4. Knut and Alice Wallenberg Foundation
  5. Centre for Biosciences
  6. Jonasson donation to the School of Technology and Health, Kungliga Tekniska Hogskolan, Huddinge, Sweden

向作者/读者索取更多资源

Objective In IBD, interleukin-23 (IL-23) and its receptor (IL-23R) are implicated in disease initiation and progression. Novel insight into which cells produce IL-23 at the site of inflammation at an early stage of IBD will promote the development of new tools for diagnosis, treatment and patient monitoring. We examined the cellular source of IL-23 in colon tissue of untreated newly diagnosed paediatric patients with IBD. Design Colon tissues from IBD and non-IBD patients were analysed by quantitative real-time PCR (qPCR), immunofluorescence confocal microscopy and flow cytometry after appropriate sample preparation. Blood samples from IBD and non-IBD patients and healthy controls were analysed using flow cytometry and qPCR. Results We discovered that tissue-infiltrating neutrophils were the main source of IL-23 in the colon of paediatric patients with IBD, while IL-23(+) human leucocyte antigen-DR+ or IL-23(+) CD14(+) cells were scarce or non-detectable, respectively. The colonic IL-23(+) neutrophils expressed C-X-C motif (CXC) R1 and CXCR2, receptors for the CXC ligand 8 (CXCL8) chemokine family, and a corresponding CXCR1(+) CXCR2(+) IL23(+) subpopulation of neutrophils was also identified in the blood of both patients with IBD and healthy individuals. However, CXCL8-family chemokines were only elevated in colon tissue from patients with IBD. Conclusions This study provides the first evidence of CXCR1(+) CXCR2(+) IL-23-producing neutrophils that infiltrate and accumulate in inflamed colon tissue of patients with IBD. Thus, this novel source of IL-23 may play a key role in disease progression and will be important to take into consideration in the development of future strategies to monitor, treat and prevent IBD.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据